The independent source for health policy research, polling, and news.
12,721-12,740 of 112,920 results
Despite urging from some health experts for people to upgrade from cloth masks to medical-grade ones due to the contagious nature of the omicron variant, Centers for Disease Control and Prevention Director Rochelle Walensky says that the agency does not plan to change its recommendations. The White House is moving forward with a plan to provide higher-quality masks for free though.
Today's early morning highlights from the major news organizations.
Editorial writers tackle these public health topics.
Opinion writers weigh in on these covid and vaccine issues.
A state Assembly committee advanced a bill that would create a universal health care system and set its rules. A separate bill is planned to fund the proposal at about $163 billion a year. Republicans opposed the bill saying it would cost too much and could even lower the pay for health workers.
Read recent commentaries about drug-cost issues.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
CMS Administrator Chiquita Brooks-LaSure tells a financial conference that the federal Medicare and Medicaid programs need to "align goals" with private companies to help lower drug costs and other health expenses.
Leaking military fuel from an old dump in Hawaii was blamed for causing discolored smelly water, and symptoms among local people like diarrhea, nausea, headaches, and eye and skin irritation. Facing criticism, the Navy has now promised to clean up the problem.
The updated guidelines address coverage for electric breast pumps for breastfeeding, which now must be a priority, counseling for overweight or typically-weighted women ages 40 to 60, plus screening, education, counseling and provision of contraceptive care and more.
Half the tests will be rapid tests, and half will be the PCR versions. The drive is part of an effort to keep classrooms open. Meanwhile, The New York Times reports on why covid testing is falling short in many schools, with expired kits, labor disputes and more hobbling their efforts.
Nearly a million tests sitting in a state warehouse expired at the end of last year, but the state has now been given a three-month extension to use them. Meanwhile, hospitals in Kentucky are asking people to not clutter up their emergency rooms by seeking routine covid tests.
The tests mainly affect those exempted from the general federal worker vax mandate. Also: Indoor masking in New Orleans, the end of active contact tracing in New York and more.
NPR reports that 145,982 people are hospitalized due to the effects of covid, beating the previous record from January 2021. Meanwhile, a study of California covid patients shows omicron seemingly does cause less severe disease than other variants, aligning with data found in other countries.
An Oregon State University study analyzing a range of botanical compounds discovered that two found in hemp can bind to the virus that causes covid and prevent it from infecting human cells. In the lab tests, researchers used the original virus and the alpha and beta variants, but no subsequent strains. Smoking cannabis does not offer any protection, the lead researcher said.
Meanwhile, Republican West Virginia Gov. Jim Justice, 70, tested positive Tuesday and said he was feeling "extremely unwell."
As omicron infections rage in the U.S., Biden administration health officials faced pointed questions — from lawmakers on both sides of the aisle — as they defended the federal pandemic response to a Senate panel Tuesday. Testing, school safety and access to covid treatments were among the points of contention.
Acting FDA head Janet Woodcock told senators during a hearing Tuesday that "most people are going to get covid." Dr. Anthony Fauci repeated the warning in an interview. And, in yet another heated exchange between the two men, Fauci called out Sen. Rand Paul's personal attacks and false claims, saying they've led to death threats against him and his family.
The Centers for Medicare and Medicaid Services says it will pay for Adulhelm, Biogen's $28,000-a-year treatment for Alzheimer's disease, but initially plans to restrict coverage to patients with early-stage symptoms who enroll in a clinical trial supported by the National Institutes of Health. The move reflects ongoing concerns over safety and effectiveness of the drug.
Today's early morning highlights from the major news organizations.
© 2026 KFF